Steven Xie

Steven joins Circle Pharma with over 13 year’s experience working on early stage formulation development. Prior to joining Circle Pharma, Steven spent over seven years developing and supporting pre-clinical PK/efficacy formulations for all oncology discovery programs at Abbvie/Legacy Pharmacyclics. Steven contributed heavily to the formulation and tech transfer for pediatric oral Imbruvica. Steven holds a B.S. in Integrative Biology from UC Berkeley.